Clinical trial

Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass

NCT02340247

Study summary

ClinicalTrials.gov

Effects of Bile Acids on GLP-1 Secretion After Roux-en-Y Gastric Bypass

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

OTHER · Unmapped registry intervention Water Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Ursodeoxycholic Acid Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Chenodeoxycholic Acid Normalized identity: chenodeoxycholic acid View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-11-01

PhasePHASE4

Conditions

Severe Obesityunresolved

Interventions

WaterOTHER

Ursodeoxycholic AcidDRUG

Chenodeoxycholic AcidDRUG · verified · RxNorm: chenodeoxycholic acid

Sponsors & collaborators

Hvidovre University Hospitallead sponsor

University of Copenhagencollaborator

Mapped research locations

HvidovreDenmark1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02340247 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.